Response to Letter to the Editor Regarding OpT2mise Study

Ignacio Conget; Ronnie Aronson; Ohad Cohen; Yves Reznik

doi:10.1089/dia.2016.0081

Response to Letter to the Editor Regarding OpT2mise Study

Ignacio Conget^*, Ronnie Aronson, Ohad Cohen, Yves Reznik

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	448
Number of pages	1
Journal	Diabetes Technology and Therapeutics
Volume	18
Issue number	7
DOIs	https://doi.org/10.1089/dia.2016.0081
State	Published - Jul 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1089/dia.2016.0081

Cite this

@article{d2fa4cdf1e68462f952c31096e8ba77d,

title = "Response to Letter to the Editor Regarding OpT2mise Study",

author = "Ignacio Conget and Ronnie Aronson and Ohad Cohen and Yves Reznik",

year = "2016",

month = jul,

doi = "10.1089/dia.2016.0081",

language = "אנגלית",

volume = "18",

pages = "448",

journal = "Diabetes Technology and Therapeutics",

issn = "1520-9156",

publisher = "Mary Ann Liebert Inc.",

number = "7",

}

TY - JOUR

T1 - Response to Letter to the Editor Regarding OpT2mise Study

AU - Conget, Ignacio

AU - Aronson, Ronnie

AU - Cohen, Ohad

AU - Reznik, Yves

PY - 2016/7

Y1 - 2016/7

UR - http://www.scopus.com/inward/record.url?scp=84978097002&partnerID=8YFLogxK

U2 - 10.1089/dia.2016.0081

DO - 10.1089/dia.2016.0081

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 27043892

AN - SCOPUS:84978097002

SN - 1520-9156

VL - 18

SP - 448

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

IS - 7

ER -

Response to Letter to the Editor Regarding OpT2mise Study

UN SDGs

Access to Document

Other files and links

Cite this